Office of Biostatistics Cytel Software (Base)
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 519130 Internet Publishing and Broadcasting and Web Search Portals
- Points of contact
-
- CDER Acquisition Liaison cderacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring Cytel Software licenses and related tools for the Office of Biostatistics to support review work involving power and sample size calculations, adaptive designs using EAST, and exact statistical calculations using StatXact. The solicitation is estimated to release on May 1, 2027, with award anticipated by September 1, 2027.
The estimated award value ranges from $25,000 to $250,000. The requirement includes StatXact Procs with SARGE (SAS) integration, with cost increases driven in part by expanded functionality in this component. Point of contact for inquiries is the Acquisition Liaison at cderacquisitions@fda.hhs.gov.
Forecast text
Office of Biostatistics Cytel Software Required for review work, specifically power and sample size calculations, adaptive designs (EAST), exact statistical calculations (StatXact). Increased cost driven in part by additional cost due to increase in costs of StatXact Procs with SARGE (SAS).
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast